Adrian Shields

Clinical Lecturer

University of Birmingham

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Immunology Immunology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Adrian Shields is a Clinical Lecturer at the University of Birmingham, UK. His research focuses on antibody deficiencies, vaccine immunogenicity, and the clinical outcomes related to immunocompromised populations. Recent publications include studies on immunodeficiency following hematological malignancies, COVID-19 responses in patients with antibody deficiencies, and the implications of immunoglobulin replacement therapies.

Articles (13)

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (3)

Fiona Moghaddas

North Bristol NHS Trust

UNITED KINGDOM

View details

Harriet Hill

University of Birmingham

UNITED KINGDOM

View details

Praveen Sharma

University of Birmingham

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Adrian Shields

Research Interests

Explore related searches

Contact this professor

About

Articles (13)

Serum sBCMA in primary and secondary antibody deficiency

Learning from inborn errors of immunity and secondary immune deficiencies about vaccine immunogenicity, efficacy, and safety

Comparison of short- and long-term humoral immune responses to pneumococcal polysaccharide and glycoconjugate vaccines in an HIV-infected population

Dose reductions in immunoglobulin replacement are associated with increased antibiotic usage in patients with antibody deficiency

Clinical and laboratory characteristics of patients with symptomatic secondary immunodeficiency following the treatment of haematological malignancies

Outcomes following SARS-CoV-2 infection in patients with primary and secondary immunodeficiency in the UK

COVID-19: Seroprevalence and Vaccine Responses in UK Dental Care Professionals

Correction to: Resolution of Persistent COVID-19 After Convalescent Plasma in a Patient with B Cell Aplasia

Resolution of Persistent COVID-19 After Convalescent Plasma in a Patient with B Cell Aplasia

Genetic polymorphisms, vitamin D binding protein and vitamin D deficiency in COVID-19

Vitamin D status and seroconversion for COVID-19 in UK healthcare workers

COVID-19 in patients with primary and secondary immunodeficiency: the United Kingdom experience.

A Novel, Heterozygous Three Base-Pair Deletion in CARD11 Results in B Cell Expansion with NF-κB and T Cell Anergy Disease

Collaborators (3)

Fiona Moghaddas

Harriet Hill

Praveen Sharma

Make your next move.